• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过血液透析清除低渗造影剂。

Elimination of low-osmolality contrast media by hemodialysis.

作者信息

Furukawa T, Ueda J, Takahashi S, Sakaguchi K

机构信息

Department of Radiology, Sumitomo Hospital, Osaka, Japan.

出版信息

Acta Radiol. 1996 Nov;37(6):966-71. doi: 10.1177/02841851960373P2104.

DOI:10.1177/02841851960373P2104
PMID:8995475
Abstract

PURPOSE

To compare the dialyzability and safety of 2 types of low-osmolality contrast media administered to end-stage renal failure patients maintained on regular hemodialysis.

MATERIAL AND METHODS

Of 44 CT examinations, iohexol was used in 22 and ioxaglate in the other 22. Adverse reactions and hemodynamic changes were recorded. Thirty minutes after the beginning of CT investigation, hemodialysis was commenced. Elimination rate and clearance of the contrast media were measured as indices of their dialyzability.

RESULTS

After 4 hours of hemodialysis, 78.4+/-6.5% of iohexol and 72.4+/-6.0% ioxaglate were eliminated. Clearance of iohexol was higher than that of ioxaglate at all sampling times. No severe hemodynamic change nor adverse reaction were observed. Minor reactions were more frequently observed in the ioxaglate group.

CONCLUSION

Iohexol, a nonionic monomeric contrast medium, is more advantageous for hemodialysis patients than ioxaglate, an ionic dimeric contrast medium.

摘要

目的

比较两种低渗性造影剂用于维持性规律血液透析的终末期肾衰竭患者时的透析性和安全性。

材料与方法

44例CT检查中,22例使用碘海醇,另22例使用碘克沙醇。记录不良反应和血流动力学变化。CT检查开始30分钟后开始血液透析。测量造影剂的清除率和消除率作为其透析性指标。

结果

血液透析4小时后,碘海醇的消除率为78.4±6.5%,碘克沙醇为72.4±6.0%。在所有采样时间点,碘海醇的清除率均高于碘克沙醇。未观察到严重血流动力学变化和不良反应。碘克沙醇组轻微反应更常见。

结论

对于血液透析患者,非离子单体造影剂碘海醇比离子二聚体造影剂碘克沙醇更具优势。

相似文献

1
Elimination of low-osmolality contrast media by hemodialysis.通过血液透析清除低渗造影剂。
Acta Radiol. 1996 Nov;37(6):966-71. doi: 10.1177/02841851960373P2104.
2
Elimination of iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure.
Nephron. 1990;56(1):81-5. doi: 10.1159/000186105.
3
Elimination of non-ionic contrast medium by hemodialysis in patients with impaired renal function.肾功能受损患者通过血液透析清除非离子型造影剂。
Nihon Ika Daigaku Zasshi. 1999 Oct;66(5):305-7. doi: 10.1272/jnms.66.305.
4
The effect of iodinated contrast agent properties on renal kinetics and oxygenation.碘造影剂性质对肾功能和氧合的影响。
Invest Radiol. 2013 Apr;48(4):175-82. doi: 10.1097/RLI.0b013e31827b70f9.
5
Assessing residual renal function and efficiency of hemodialysis--an application for urographic contrast media.评估残余肾功能及血液透析效率——尿路造影剂的一项应用
Nephron. 2000 Aug;85(4):324-33. doi: 10.1159/000045682.
6
Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention.
Nephron. 1996;73(4):549-56. doi: 10.1159/000189139.
7
Elimination of the nonionic contrast medium iopromide in end-stage renal failure by hemodialysis.血液透析清除终末期肾衰竭患者体内的非离子型造影剂碘普罗胺。
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989;128:119-23.
8
Hemodialysis for elimination of the nonionic contrast medium iohexol after angiography in patients with impaired renal function.肾功能受损患者血管造影后采用血液透析清除非离子型造影剂碘海醇。
Nephron. 1995;70(4):430-7. doi: 10.1159/000188641.
9
In vivo comparative antithrombotic effects of ioxaglate and iohexol and interaction with the platelet antiaggregant clopidogrel.碘克沙醇与碘海醇的体内抗血栓形成比较效应以及与血小板抗聚集剂氯吡格雷的相互作用。
Invest Radiol. 2003 Jan;38(1):34-43. doi: 10.1097/00004424-200301000-00005.
10
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.一项关于生理盐水水化预防慢性肾衰竭患者造影剂肾病的随机试验。
Nephrol Dial Transplant. 2006 Aug;21(8):2120-6. doi: 10.1093/ndt/gfl133. Epub 2006 Apr 12.

引用本文的文献

1
Measurement and Estimation of Residual Kidney Function in Patients on Dialysis.透析患者残余肾功能的测量和评估。
Adv Chronic Kidney Dis. 2018 Jan;25(1):93-104. doi: 10.1053/j.ackd.2017.09.001.
2
Clearance and safety of the radiocontrast medium iopamidol in peritoneal dialysis patients.放射性造影剂碘帕醇在腹膜透析患者中的清除率及安全性
Int J Nephrol. 2011;2011:657051. doi: 10.4061/2011/657051. Epub 2011 Oct 19.
3
Contrast-induced acute kidney injury and diabetic nephropathy.对比剂诱导的急性肾损伤与糖尿病肾病。
Nat Rev Nephrol. 2010 Nov;6(11):679-88. doi: 10.1038/nrneph.2010.116. Epub 2010 Sep 28.
4
Contrast induced nephropathy in urology.泌尿外科中的对比剂肾病
Indian J Urol. 2009 Oct-Dec;25(4):437-45. doi: 10.4103/0970-1591.57904.
5
A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial.一项比较水化疗法与额外血液透析或N-乙酰半胱氨酸预防造影剂肾病的随机对照试验:透析与利尿(DVD)试验。
Clin Res Cardiol. 2007 Mar;96(3):130-9. doi: 10.1007/s00392-007-0473-4. Epub 2006 Dec 22.
6
Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients.从实验台到病床的综述:危重症患者对比剂肾病的预防措施
Crit Care. 2005 Aug;9(4):361-70. doi: 10.1186/cc3028. Epub 2005 Jan 7.